Robert Chung

Partner, New York

Biography

Overview

Robert has represented acquirers, targets, boards of directors, special committees and investment banks across a variety of transactions. Committed to achieving the best possible outcome for his clients, his extensive experience and knowledge enable him to navigate a wide range of complex deals, whether domestic or cross-border, negotiated or unsolicited, public or private.

Robert has experience on several high-profile billion dollar transactions, including Zimmer Holdings, Inc.'s US$13.35 billion acquisition of LVB Acquisition, Inc. and Omnicare, Inc. in its US$12.7 billion sale to CVS Health Corporation. He also represented MetLife, Inc. in its US$16.2 billion acquisition of American Life Insurance Company. His experience extends across several industry sectors including the entertainment, retail, insurance, energy, technology, healthcare and pharmaceutical industries.

Robert is a partner in the Mergers & Acquisitions Group, a global practice focusing on effective deal execution and optimized efficiency for clients across a variety of large and complex transactions.

Bars and Courts
California State Bar
New York State Bar
District of Columbia Bar
US District Court for the Central District of California
Appellate Division, First Judicial Department, New York
Education
JD
Northwestern University School of Law
BA
Brown University
Languages
English
Korean

Experience

Calpine Corporation
Robert represented Calpine Corporation in its US$17 billion sale to Energy Capital Partners, an energy-focused private equity firm, and a consortium of investors including Access Industries and Canadian Pension Plan Investment Board.

Zimmer Holdings, Inc.
Robert represented Zimmer Holding's, Inc. in its acquisition of LVB Acquisition, Inc.

Zimmer Biomet
Robert represented Zimmer Biomet, in its acquisition of LDR Holding Corporation.

Omnicare, Inc.
Robert represented Omnicare, Inc., in its sale to CVS Health Corporation.

Illumina, Inc.
Robert represented Illumina, Inc. in its defense against Roche Holding Ltd.'s unsolicited cash tender offer and proxy contest.

Omnicare, Inc.
Robert represented Omnicare, Inc. in its unsolicited cash tender offer for PharMerica Corporation.

Sony Corporation of America
Robert represented Sony/ATV and EMI Music Publishing in the sale of selected music catalogs, including catalogs owned by Virgin Music Publishing Companies and Famous UK Music Publishing, to BMG, the world’s fourth-largest music publishing company.

MetLife, Inc.
Robert represented MetLife, Inc. in its acquisition of American Life Insurance Company and certain subsequent divestitures of businesses of American Life Insurance Company.

Alimentation Couche-Tard Inc.
Robert represented Alimentation Couche-Tard Inc. in its unsolicited cash tender offer for Casey's General Stores, Inc.

Applied Materials, Inc.
Robert represented Applied Materials, Inc. in its acquisition of Semitool, Inc.

Nordic Capital, DLJ Merchant Banking, Avista Capital et al.
Robert represented Nordic Capital, DLJ Merchant Banking, Avista Capital and other private equity sponsors in their sale of Fougera Pharmaceuticals to Sandoz.

First Advantage Corporation
Robert represented First Advantage Corporation in the acquisition by The First American Corporation of the outstanding minority interests of First Advantage Corporation.

Fisher Communications, Inc.
Robert represented Fisher Communications, Inc. in its sale to Sinclair Broadcast Group, Inc.

The Talbots, Inc.
Robert represented The Talbots, Inc. in its sale to Sycamore Partners, and in its sale of the J. Jill business to Golden Gate Capital.

King Pharmaceuticals, Inc.
Robert represented King Pharmaceuticals, Inc. in its US$1.6 billion unsolicited acquisition of Alpharma Inc.